In Cox regression models, women with TN BC (HR: 3.02, 95% CI = 1.94–4.70) and those HER-2+ (HR: 1.79, 95% CI = 1.12–2.87) had higher risk of death as compared to those with Luminal-A disease. Here, ERBB2 is linked to breast cancer.